Market capitalization | $5.30b |
Enterprise Value | $4.94b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 48.24 |
EV/Sales (TTM) EV/Sales | 12.82 |
P/S ratio (TTM) P/S ratio | 13.75 |
P/B ratio (TTM) P/B ratio | 17.76 |
Revenue growth (TTM) Revenue growth | 25.82% |
Revenue (TTM) Revenue | $385.17m |
As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.
8 Analysts have issued a Cellebrite DI forecast:
8 Analysts have issued a Cellebrite DI forecast:
Sep '24 |
+/-
%
|
||
Revenue | 385 385 |
26%
26%
|
|
Gross Profit | 325 325 |
27%
27%
|
|
EBITDA | 67 67 |
76%
76%
|
EBIT (Operating Income) EBIT | 56 56 |
101%
101%
|
Net Profit | -317 -317 |
434%
434%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.
Head office | Israel |
CEO | Thomas Hogan |
Employees | 1,008 |
Founded | 1999 |
Website | www.cellebrite.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.